Drogueria Saimed S.a. DE C.v., Pharmaceutical Import Profile — El Salvador (DGFT 2022–2026)

Name: Drogueria Saimed S.a. DE C.v., Pharmaceutical Import Records from India — 5 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Drogueria Saimed S.a. DE C.v., — Pharmaceutical Importer Profile (2026) | 5 Products, $3.8M Trade | TransData Nexus

Drogueria Saimed S.a. DE C.v.,

Pharmaceutical Importer · El Salvador · Nutritional Supplements Focus · $3.8M Total Trade · DGFT Verified

Drogueria Saimed S.a. DE C.v., is a pharmaceutical importer based in El Salvador with a total trade value of $3.8M across 5 products in 3 therapeutic categories. Based on 117 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Drogueria Saimed S.a. DE C.v., sources from 1 verified Indian supplier, with Caplin Point Laboratories Limited accounting for 100.0% of imports.

Drogueria Saimed S.a. DE C.v., — Import Portfolio & Supplier Network

Drogueria Saimed S.a. DE C.v., import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Drogueria Saimed S.a. DE C.v.,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$4.4M	227	100.0%

Drogueria Saimed S.a. DE C.v., sources from 1 verified Indian supplier across 137 distinct formulations. The sourcing is highly concentrated — Caplin Point Laboratories Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ibuprofen soft gelatin capsules 800MG	$250.0K	5
Clarithromycin tablets USP 500MG	$235.0K	6
Sildenafil citrate tablets 100MG	$200.0K	4
Gentamycinbetamethasone and clotrimazole cream 30GM gentamicina + betametasona+ clotrimazol crema 30GM	$150.0K	3
Carbamazepine tablets BP 200MG	$149.3K	7
Omeprazole delayed release capsules usp20mg	$145.4K	7
Ibuwin forte ibuprofen soft gelatin	$100.0K	2
Gentamycinbetamethasone and	$100.0K	2
Gentamycin,betamethasone and clotrimazole cream 30GM gentamicina + betametasona+ clotrimazol crema 30GM	$100.0K	2
Simethicone tablets USP 40MG	$92.5K	10
Ibuprofen soft gelatin capsules 600MG ibuwin plus ibuwin plus ibuprofeno 600MG	$89.5K	2
Gentamicin+betamethasone+clotrimazole	$78.8K	2
Allopurinol tablets USP 300MG	$73.3K	3
Sildenafil citrate tablets USP 100MG	$64.0K	2
Cyanocobalamin injection USP 1000mcg ML 10 000mcg 10ML	$62.9K	2

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Vitamin	Nutritional Supplements	$1.2M	55	0.9%	14
2	Clarithromycin	Antibiotics	$850.0K	17	0.9%	19
3	Clotrimazole	Antifungals	$729.0K	19	0.8%	14
4	Gentamicin	Antibiotics	$650.0K	13	1.3%	7
5	Omega	Nutritional Supplements	$293.4K	13	0.9%	8

Drogueria Saimed S.a. DE C.v., imports 5 pharmaceutical products across 3 categories into El Salvador totaling $3.8M.

Drogueria Saimed S.a. DE C.v., — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Drogueria Saimed S.A. de C.V. is a pharmaceutical importer and distributor based in San Salvador, El Salvador. The company specializes in sourcing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $3.8 million USD and 117 shipments from 2022 to 2026, Drogueria Saimed plays a significant role in the El Salvadorian pharmaceutical market. The company's product portfolio encompasses five key products across three therapeutic categories: Nutritional Supplements, Antibiotics, and Antifungals. Notably, their top five imported products include Vitamin supplements, Clarithromycin, Clotrimazole, Gentamicin, and Omega supplements. All these products are sourced exclusively from Caplin Point Laboratories Limited, an Indian pharmaceutical manufacturer.

2Distribution Network

Drogueria Saimed's distribution network is centered in San Salvador, the capital city of El Salvador. While specific details about their warehouse locations and logistics capabilities are not publicly disclosed, the company's significant import volume suggests a well-established infrastructure capable of handling substantial pharmaceutical shipments. Their geographic coverage likely extends throughout El Salvador, ensuring nationwide distribution of their imported pharmaceutical products.

3Industry Role

In El Salvador's pharmaceutical supply chain, Drogueria Saimed functions primarily as a wholesaler and distributor. By importing finished pharmaceutical formulations from India and distributing them within the local market, the company bridges the gap between international manufacturers and local healthcare providers. Their focus on sourcing from a single supplier indicates a streamlined approach to procurement and distribution.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Drogueria Saimed S.a. DE C.v.,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Drogueria Saimed's sourcing strategy exhibits a high degree of concentration, with all 117 shipments from 2022 to 2026 originating from Caplin Point Laboratories Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or geopolitical issues affecting India. However, the consistent volume of imports and the exclusive partnership suggest a stable and reliable relationship between Drogueria Saimed and Caplin Point Laboratories. The absence of alternative suppliers may limit flexibility in response to market changes or supply chain challenges.

2Supply Chain Resilience

The resilience of Drogueria Saimed's supply chain is closely tied to its exclusive relationship with Caplin Point Laboratories Limited. While this partnership ensures consistency in product quality and availability, it also means that any disruptions at Caplin Point Laboratories—such as production issues, regulatory challenges, or logistical problems—could directly impact Drogueria Saimed's ability to meet local demand. The company's reliance on a single supplier may limit its capacity to diversify sourcing options in response to unforeseen events.

3Strategic Implications

Importing Pharmaceuticals into El Salvador — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for El Salvador

1Regulatory Authority & Framework

In El Salvador, the Ministry of Health (Ministerio de Salud) is the primary regulatory authority overseeing pharmaceutical imports and distribution. The regulatory framework governing pharmaceutical imports includes compliance with Good Manufacturing Practices (GMP), product registration, and adherence to labeling and packaging standards. Indian pharmaceutical products must undergo a registration process with the Ministry of Health to obtain marketing authorization before they can be imported and distributed within El Salvador.

2Import Licensing & GMP

Import licensing in El Salvador requires pharmaceutical companies to obtain authorization from the Ministry of Health, demonstrating compliance with national regulations and standards. GMP certificates from recognized authorities, such as the World Health Organization (WHO) or the European Medicines Agency (EMA), are typically accepted, provided they are current and cover the specific products intended for import. Additionally, wholesale distribution authorization is necessary to legally distribute pharmaceutical products within the country.

3Quality & Labeling

Drogueria Saimed S.a. DE C.v., — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Drogueria Saimed's focus on importing Nutritional Supplements, Antibiotics, and Antifungals aligns with prevalent health concerns in El Salvador, such as infectious diseases and nutritional deficiencies. The market demand for these products is driven by the need for effective treatments and preventive measures. By concentrating on these therapeutic areas, Drogueria Saimed addresses critical health issues while capitalizing on high-demand segments within the pharmaceutical market.

2Sourcing Profile

Drogueria Saimed's sourcing strategy is centered on generic drug formulations, primarily sourced from India. The company's exclusive partnership with Caplin Point Laboratories Limited indicates a preference for established suppliers with a proven track record in product quality and regulatory compliance. This approach ensures a consistent supply of affordable and effective pharmaceutical products for the Salvadoran market.

3Market Positioning

Drogueria Saimed serves the wholesale distribution segment of the El Salvadorian pharmaceutical market. By importing and distributing a range of pharmaceutical products, the company supplies local pharmacies, hospitals, and healthcare providers with essential medications. Their focus on high-demand therapeutic areas positions them as a key player in meeting the country's healthcare needs.

Seller's Guide — How to Become a Supplier to Drogueria Saimed S.a. DE C.v.,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Salvadoran market through partnerships with Drogueria Saimed. The company's established distribution network and focus on high-demand therapeutic areas present a viable channel for introducing additional products. Potential gaps in Drogueria Saimed's current sourcing include a limited supplier base and a narrow product range. New suppliers can address these gaps by offering complementary products or alternative formulations to diversify the company's portfolio.

2Requirements & Qualifications

Indian exporters seeking to supply Drogueria Saimed must ensure their products are registered with El Salvador's Ministry of Health and comply with local GMP standards. Products should have current GMP certificates from recognized authorities such as WHO or EMA. Additionally, exporters must provide labeling in Spanish that meets El Salvador's regulatory requirements, including all necessary product information and safety warnings.

3How to Approach

Frequently Asked Questions — Drogueria Saimed S.a. DE C.v.,

What products does Drogueria Saimed S.a. DE C.v., import from India?

Drogueria Saimed S.a. DE C.v., imports 5 pharmaceutical products across 3 categories. Top imports: Vitamin ($1.2M), Clarithromycin ($850.0K), Clotrimazole ($729.0K), Gentamicin ($650.0K), Omega ($293.4K).

Who supplies pharmaceuticals to Drogueria Saimed S.a. DE C.v., from India?

Drogueria Saimed S.a. DE C.v., sources from 1 verified Indian suppliers. The primary supplier is Caplin Point Laboratories Limited (100.0% of imports, $4.4M).

What is Drogueria Saimed S.a. DE C.v.,'s total pharmaceutical import value?

Drogueria Saimed S.a. DE C.v.,'s total pharmaceutical import value from India is $3.8M, based on 117 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Drogueria Saimed S.a. DE C.v., focus on?

Drogueria Saimed S.a. DE C.v., imports across 3 categories. The largest: Nutritional Supplements (40.8%), Antibiotics (39.9%), Antifungals (19.4%).

Get Full Drogueria Saimed S.a. DE C.v., Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.